$AVD
AMERICAN VANGUARD CORP

2016 Q3 Form 10-Q Financial Statement

#000156459016026972 Filed on November 02, 2016

View on sec.gov

Income Statement

Concept 2016 Q3 2016 Q2 2015 Q3
Revenue $82.45M $72.72M $72.49M
YoY Change 13.74% 9.32% 1.19%
Cost Of Revenue $49.50M $41.33M $41.05M
YoY Change 20.58% -0.18% -5.28%
Gross Profit $32.99M $31.40M $31.43M
YoY Change 4.94% 24.98% 11.1%
Gross Profit Margin 40.01% 43.17% 43.36%
Selling, General & Admin $23.10M $20.00M $21.60M
YoY Change 6.94% 7.53% 0.47%
% of Gross Profit 70.03% 63.7% 68.72%
Research & Development $5.200M $6.200M $4.500M
YoY Change 15.56% 16.98% -13.46%
% of Gross Profit 15.76% 19.75% 14.32%
Depreciation & Amortization $2.021M $2.059M $2.231M
YoY Change -9.41% -47.34% -44.23%
% of Gross Profit 6.13% 6.56% 7.1%
Operating Expenses $28.20M $26.27M $26.06M
YoY Change 8.22% 9.82% -4.78%
Operating Profit $4.786M $5.125M $5.374M
YoY Change -10.94% 327.44% 480.35%
Interest Expense -$300.0K $462.0K $700.0K
YoY Change -142.86% -30.21% -12.94%
% of Operating Profit -6.27% 9.01% 13.03%
Other Income/Expense, Net
YoY Change
Pretax Income $4.400M $4.663M $4.736M
YoY Change -7.09% 768.34% 3121.77%
Income Tax $1.400M $1.234M $1.643M
% Of Pretax Income 31.82% 26.46% 34.69%
Net Earnings $2.877M $3.246M $2.772M
YoY Change 3.79% 315.62% 278.69%
Net Earnings / Revenue 3.49% 4.46% 3.82%
Basic Earnings Per Share $0.10 $0.11 $0.10
Diluted Earnings Per Share $0.10 $0.11 $0.09
COMMON SHARES
Basic Shares Outstanding 29.35M shares 28.89M 28.75M shares
Diluted Shares Outstanding 29.38M 29.29M shares

Balance Sheet

Concept 2016 Q3 2016 Q2 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.600M $5.800M $5.400M
YoY Change 22.22% 13.73% 8.0%
Cash & Equivalents $6.594M $5.799M $5.429M
Short-Term Investments
Other Short-Term Assets $20.40M $22.10M $20.80M
YoY Change -1.92% 1.38% 0.97%
Inventory $141.7M $151.1M $161.5M
Prepaid Expenses $12.27M $13.98M
Receivables $91.09M $76.15M $89.72M
Other Receivables $3.500M $3.394M $4.872M
Total Short-Term Assets $263.2M $258.5M $283.6M
YoY Change -7.19% -7.17% -2.71%
LONG-TERM ASSETS
Property, Plant & Equipment $47.76M $45.39M $48.46M
YoY Change -1.44% -7.32% -5.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.592M
YoY Change -14.23%
Other Assets $28.70M $30.33M $30.83M
YoY Change -6.92% -6.43% -16.76%
Total Long-Term Assets $199.9M $201.1M $210.3M
YoY Change -4.95% -6.24% 10.42%
TOTAL ASSETS
Total Short-Term Assets $263.2M $258.5M $283.6M
Total Long-Term Assets $199.9M $201.1M $210.3M
Total Assets $463.1M $459.7M $493.9M
YoY Change -6.24% -6.76% 2.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.27M $25.18M $23.42M
YoY Change -0.65% 25.78% 30.59%
Accrued Expenses $74.91M $62.33M $73.53M
YoY Change 1.88% -10.45% 1.01%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $18.00K $10.07M
YoY Change -100.0% -99.82% 14087.32%
Total Short-Term Liabilities $109.8M $104.7M $114.7M
YoY Change -4.26% -6.01% 13.94%
LONG-TERM LIABILITIES
Long-Term Debt $44.49M $49.58M $82.66M
YoY Change -46.18% -43.42% -13.06%
Other Long-Term Liabilities $3.036M $3.029M $3.003M
YoY Change 1.1% 1.17% -11.15%
Total Long-Term Liabilities $47.52M $52.61M $85.66M
YoY Change -44.52% -41.94% -12.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $109.8M $104.7M $114.7M
Total Long-Term Liabilities $47.52M $52.61M $85.66M
Total Liabilities $184.8M $184.8M $228.5M
YoY Change -19.09% -19.68% 2.88%
SHAREHOLDERS EQUITY
Retained Earnings $217.1M $214.3M $205.5M
YoY Change 5.65% 5.68% 2.12%
Common Stock $73.64M $72.62M $71.63M
YoY Change 2.81% 2.46% 2169.61%
Preferred Stock
YoY Change
Treasury Stock (at cost) $8.269M $8.269M $8.269M
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares $2.451M 2.451M shares 2.451M shares
Shareholders Equity $278.1M $274.6M $265.4M
YoY Change
Total Liabilities & Shareholders Equity $463.1M $459.7M $493.9M
YoY Change -6.24% -6.76% 2.48%

Cashflow Statement

Concept 2016 Q3 2016 Q2 2015 Q3
OPERATING ACTIVITIES
Net Income $2.877M $3.246M $2.772M
YoY Change 3.79% 315.62% 278.69%
Depreciation, Depletion And Amortization $2.021M $2.059M $2.231M
YoY Change -9.41% -47.34% -44.23%
Cash From Operating Activities $10.71M $15.90M $7.990M
YoY Change 34.04% -33.69% -266.46%
INVESTING ACTIVITIES
Capital Expenditures -$4.390M -$1.010M -$1.720M
YoY Change 155.23% -48.47% -14.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$230.0K $0.00
YoY Change -99.37%
Cash From Investing Activities -$4.390M -$1.240M -$1.720M
YoY Change 155.23% -96.78% -14.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.080M -16.21M -5.060M
YoY Change 0.4% -225.76% -162.7%
NET CHANGE
Cash From Operating Activities 10.71M 15.90M 7.990M
Cash From Investing Activities -4.390M -1.240M -1.720M
Cash From Financing Activities -5.080M -16.21M -5.060M
Net Change In Cash 1.240M -1.550M 1.210M
YoY Change 2.48% -6.06% -4.72%
FREE CASH FLOW
Cash From Operating Activities $10.71M $15.90M $7.990M
Capital Expenditures -$4.390M -$1.010M -$1.720M
Free Cash Flow $15.10M $16.91M $9.710M
YoY Change 55.51% -34.81% -446.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2016-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Trading Symbol
TradingSymbol
AVD
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
AMERICAN VANGUARD CORP
us-gaap Sales Revenue Net
SalesRevenueNet
205574000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6594000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5524000
CY2016Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
91091000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
72835000
CY2016Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
3500000
CY2015Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
2554000
CY2016Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
94591000
CY2015Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
75389000
CY2016Q3 us-gaap Inventory Net
InventoryNet
141678000
CY2015Q4 us-gaap Inventory Net
InventoryNet
136477000
CY2016Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12270000
CY2015Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11172000
CY2015Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
168000
CY2016Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
8101000
CY2015Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
8101000
CY2016Q3 us-gaap Assets Current
AssetsCurrent
263234000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
958000
CY2016Q3 avd Income Loss From Equity Method Investments Net Of Gain Loss On Dilution
IncomeLossFromEquityMethodInvestmentsNetOfGainLossOnDilution
-180000
us-gaap Operating Expenses
OperatingExpenses
74325000
us-gaap Cost Of Revenue
CostOfRevenue
124370000
us-gaap Gross Profit
GrossProfit
81204000
us-gaap Operating Income Loss
OperatingIncomeLoss
6879000
avd Income Loss From Equity Method Investments Net Of Gain Loss On Dilution
IncomeLossFromEquityMethodInvestmentsNetOfGainLossOnDilution
-580000
avd Income Loss From Equity Method Investments Net Of Gain Loss On Dilution
IncomeLossFromEquityMethodInvestmentsNetOfGainLossOnDilution
-309000
CY2016Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
289000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4938000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28653000
avd Income Loss Before Equity Method Investments
IncomeLossBeforeEquityMethodInvestments
3980000
us-gaap Interest Expense
InterestExpense
1941000
us-gaap Net Income Loss
NetIncomeLoss
3604000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29208000
us-gaap Profit Loss
ProfitLoss
3400000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-204000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2015Q3 avd Income Loss From Equity Method Investments Net Of Gain Loss On Dilution
IncomeLossFromEquityMethodInvestmentsNetOfGainLossOnDilution
-389000
dei Entity Central Index Key
EntityCentralIndexKey
0000005981
us-gaap Share Based Compensation
ShareBasedCompensation
2943000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12190000
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
3992000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
118000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
8000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
19202000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5201000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1011000
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
1519000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7925000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-8847000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
30536000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
3098000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
36200000
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
6122000
us-gaap Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
3283000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-9629000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-24000000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4885000
CY2016Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
145303000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
139591000
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
97543000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
91619000
CY2016Q3 us-gaap Depreciation
Depreciation
2021000
us-gaap Depreciation
Depreciation
6334000
CY2015Q3 us-gaap Depreciation
Depreciation
2231000
us-gaap Depreciation
Depreciation
6762000
CY2015Q1 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2014-12-11
CY2015Q4 us-gaap Assets Current
AssetsCurrent
236831000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3541000
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
463109000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
443539000
CY2016Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
159000
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
3182000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
3164000
CY2016Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
70458000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
68534000
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4429000
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47760000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47972000
CY2016Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
123420000
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
129160000
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
28695000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
29576000
CY2016Q3 us-gaap Assets
Assets
463109000
CY2015Q4 us-gaap Assets
Assets
443539000
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
55000
CY2016Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
74000
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
514000
CY2016Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
23268000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
15343000
CY2016Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
41000
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
8888000
CY2016Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
74907000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44371000
CY2016Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
10209000
CY2015Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
7111000
CY2016Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
1269000
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
109768000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
76282000
CY2016Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
44488000
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
68321000
CY2016Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3036000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3054000
CY2016Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
27556000
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
27556000
CY2016Q3 us-gaap Liabilities
Liabilities
184848000
CY2015Q4 us-gaap Liabilities
Liabilities
175213000
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
217135000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
208507000
CY2016Q3 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
286346000
CY2015Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
276664000
CY2016Q3 us-gaap Treasury Stock Value
TreasuryStockValue
8269000
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
8269000
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
278077000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
268395000
CY2016Q3 us-gaap Minority Interest
MinorityInterest
184000
CY2015Q4 us-gaap Minority Interest
MinorityInterest
-69000
CY2016Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
278261000
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
268326000
CY2015Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
679000
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
3935000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
28000
us-gaap Share Based Compensation
ShareBasedCompensation
1656000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
82000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-309000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-580000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
6172000
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
423000
CY2016Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000
CY2016Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31807223
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31638225
CY2016Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
2450634
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2450634
CY2016Q1 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
271000
CY2016Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
85000
CY2016Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
456000
CY2016Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-586000
CY2016Q1 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
35000
CY2016Q1 us-gaap Profit Loss
ProfitLoss
2947000
CY2016Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
271534000
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-537000
CY2016Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
612000
CY2016Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
120000
CY2016Q2 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
12000
CY2016Q2 us-gaap Profit Loss
ProfitLoss
3382000
CY2016Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
274834000
CY2016Q3 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
291000
CY2016Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-436000
CY2016Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
588000
CY2016Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
108000
CY2016Q3 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
35000
CY2016Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.01
CY2015Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-897000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-888000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1468000
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2441000
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1875000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8029000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2136000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12367000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4135000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1143000
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
4739000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3010000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-860000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
20982000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1615000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
51807000
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
5196000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
10000000
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
541000
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
1252000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
82000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
8000
CY2015Q2 avd Cash Dividend Paid
CashDividendPaid
572000
CY2015Q1 avd Cash Dividend Paid
CashDividendPaid
569000
CY2016Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
539000
CY2015Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
536000
us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
204000
us-gaap Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
125000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
224000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
36435000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-41756000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-16120000
us-gaap Payments Of Dividends
PaymentsOfDividends
289000
us-gaap Payments Of Dividends
PaymentsOfDividends
1141000
us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
254000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-24544000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-8251000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2027000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1800000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-957000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1256000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5429000
avd Sales Of Non Crop Products
SalesOfNonCropProducts
24620000
us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2016-06-13
CY2015Q2 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2015-03-16
us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2016-06-30
CY2015Q2 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2015-04-03
CY2015Q1 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2014-12-26
us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2016-07-12
CY2015Q2 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2015-04-17
CY2015Q1 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2015-01-09
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
499000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
555000
us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1
410000
us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1
388000
CY2016Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
123311000
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
120456000
CY2016Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
18367000
CY2015Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
16021000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2016Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
73048000
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
63641000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
192653000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
180954000
CY2016Q3 avd Sales Of Non Crop Products
SalesOfNonCropProducts
9399000
CY2015Q3 avd Sales Of Non Crop Products
SalesOfNonCropProducts
8845000
avd Sales Of Non Crop Products
SalesOfNonCropProducts
31992000
CY2016Q3 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.01
CY2015Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.02
CY2015Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.02
avd Cash Dividend Paid
CashDividendPaid
289000
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.84
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.85
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.87
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.279
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2016Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
512000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2016Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
45000000
CY2016Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0
CY2016Q3 us-gaap Line Of Credit
LineOfCredit
45000000
CY2015Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
69000000
CY2015Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0
CY2015Q4 us-gaap Line Of Credit
LineOfCredit
69000000
CY2016Q3 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
0
CY2016Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
512000
CY2015Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
679000
CY2015Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
0
CY2016Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
0
CY2016Q3 us-gaap Notes Payable Current
NotesPayableCurrent
0
CY2016Q3 us-gaap Notes Payable
NotesPayable
0
CY2015Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
0
CY2015Q4 us-gaap Notes Payable Current
NotesPayableCurrent
55000
CY2015Q4 us-gaap Notes Payable
NotesPayable
55000
CY2016Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
CY2016Q3 us-gaap Long Term Debt
LongTermDebt
44488000
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
68376000
us-gaap Line Of Credit Facility Expiration Period
LineOfCreditFacilityExpirationPeriod
P5Y
avd Line Of Credit Facility Maturity Date
LineOfCreditFacilityMaturityDate
2018-06-17
us-gaap Debt Instrument Description Of Variable Rate Basis
DebtInstrumentDescriptionOfVariableRateBasis
(i) LIBOR plus the “Applicable Rate” which is based upon the Consolidated Funded Debt Ratio (“Eurocurrency Rate Loan”) or (ii) the greater of (x) the Prime Rate, (y) the Federal Funds Rate plus 0.5%, and (z) the Daily One-Month LIBOR Rate plus 1.00%, plus, in the case of (x), (y) or (z) the Applicable Rate (“Alternate Base Rate Loan”).
CY2015Q2 avd Line Of Credit Facility Covenant Consolidated Current Assets To Consolidated Current Liabilities Ratio
LineOfCreditFacilityCovenantConsolidatedCurrentAssetsToConsolidatedCurrentLiabilitiesRatio
1.2
CY2015Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
40189000
CY2016Q3 us-gaap Share Based Compensation
ShareBasedCompensation
588000
CY2016Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4072000
CY2015Q3 us-gaap Share Based Compensation
ShareBasedCompensation
458000
CY2015Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4819000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
626845
CY2016Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
25500
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
9813
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
591532
CY2016Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
12900
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
573632
CY2016Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
15500
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
11118
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
547014
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.25
CY2016Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.50
CY2016Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.49
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.29
CY2016Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.50
CY2016Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.49
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.31
CY2016Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.50
CY2016Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.49
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.31
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.73
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.194

Files In Submission

Name View Source Status
0001564590-16-026972-index-headers.html Edgar Link pending
0001564590-16-026972-index.html Edgar Link pending
0001564590-16-026972.txt Edgar Link pending
0001564590-16-026972-xbrl.zip Edgar Link pending
avd-10q_20160930.htm Edgar Link pending
avd-20160930.xml Edgar Link completed
avd-20160930.xsd Edgar Link pending
avd-20160930_cal.xml Edgar Link unprocessable
avd-20160930_def.xml Edgar Link unprocessable
avd-20160930_lab.xml Edgar Link unprocessable
avd-20160930_pre.xml Edgar Link unprocessable
avd-ex311_8.htm Edgar Link pending
avd-ex312_7.htm Edgar Link pending
avd-ex321_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending